GRN and cancer: PGRN is involved in various neurodegenerative diseases, such as Alzheimer’s disease (AD), rare amyotrophic lateral sclerosis–frontotemporal dementia spectrum disorder (ALS-FTSD) phenotypes [95], and certain cancers, where increased PGRN expression promotes disease progression [30, 96, 97].